Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Bednarski

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
European Journal of Radiology|February 22, 2003
Apparent diffusion coefficient: a quantitative parameter for in vivo tumor characterizationAndreas M Herneth, Samira Guccione, Mark Bednarski
Academic Radiology|November 25, 2003
A primer on molecular biology for imagers: I. DNA, how does it work?Sunil D Pandit, Mark Bednarski, King C P Li
Nanomedicine : Nanotechnology, Biology, and Medicine|February 13, 2007
A review: Integrin alphavbeta3-targeted molecular imaging and therapy in angiogenesisEsther H Lim, Narasimhan Danthi, Mark Bednarski, et al.
Biochemical and Biophysical Research Communications|April 17, 2014
Novel nitric oxide generating compound glycidyl nitrate enhances the therapeutic efficacy of chemotherapy and radiotherapyShoucheng Ning, Mark Bednarski, Bryan Oronsky, et al.
Cancer Research|May 17, 2012
Dinitroazetidines are a novel class of anticancer agents and hypoxia-activated radiation sensitizers developed from highly energetic materialsShoucheng Ning, Mark Bednarski, Bryan Oronsky, et al.
Discovery Medicine|April 27, 2016
Rockets, radiosensitizers, and RRx-001: an origin story part IBryan Oronsky, Jan Scicinski, Shoucheng Ning, et al.
Investigational New Drugs|February 5, 2016
RRx-001, A novel dinitroazetidine radiosensitizerBryan Oronsky, Jan Scicinski, Shoucheng Ning, et al.
Science (New York, N.Y.)|June 29, 2002
Tumor regression by targeted gene delivery to the neovasculatureJohn D Hood, Mark Bednarski, Ricardo Frausto, et al.
Bioconjugate Chemistry|July 21, 2005
Gadolinium-rhodamine nanoparticles for cell labeling and tracking via magnetic resonance and optical imagingKien Vuu, Jianwu Xie, Michael A McDonald, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 27, 2003
Cell surface expression of single chain antibodies with applications to imaging of gene expression in vivoJeffrey P Northrop, Mark Bednarski, Susan O Barbieri, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
European Journal of Radiology|February 22, 2003
Apparent diffusion coefficient: a quantitative parameter for in vivo tumor characterizationAndreas M Herneth, Samira Guccione, Mark Bednarski
Academic Radiology|November 25, 2003
A primer on molecular biology for imagers: I. DNA, how does it work?Sunil D Pandit, Mark Bednarski, King C P Li
Nanomedicine : Nanotechnology, Biology, and Medicine|February 13, 2007
A review: Integrin alphavbeta3-targeted molecular imaging and therapy in angiogenesisEsther H Lim, Narasimhan Danthi, Mark Bednarski, et al.
Biochemical and Biophysical Research Communications|April 17, 2014
Novel nitric oxide generating compound glycidyl nitrate enhances the therapeutic efficacy of chemotherapy and radiotherapyShoucheng Ning, Mark Bednarski, Bryan Oronsky, et al.
Cancer Research|May 17, 2012
Dinitroazetidines are a novel class of anticancer agents and hypoxia-activated radiation sensitizers developed from highly energetic materialsShoucheng Ning, Mark Bednarski, Bryan Oronsky, et al.
Discovery Medicine|April 27, 2016
Rockets, radiosensitizers, and RRx-001: an origin story part IBryan Oronsky, Jan Scicinski, Shoucheng Ning, et al.
Investigational New Drugs|February 5, 2016
RRx-001, A novel dinitroazetidine radiosensitizerBryan Oronsky, Jan Scicinski, Shoucheng Ning, et al.
Science (New York, N.Y.)|June 29, 2002
Tumor regression by targeted gene delivery to the neovasculatureJohn D Hood, Mark Bednarski, Ricardo Frausto, et al.
Bioconjugate Chemistry|July 21, 2005
Gadolinium-rhodamine nanoparticles for cell labeling and tracking via magnetic resonance and optical imagingKien Vuu, Jianwu Xie, Michael A McDonald, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 27, 2003
Cell surface expression of single chain antibodies with applications to imaging of gene expression in vivoJeffrey P Northrop, Mark Bednarski, Susan O Barbieri, et al.
Pageof 1